Detect early,

treat effectively:

Driving a revolution in healthcare

Metfora’s innovative technology has the ability to detect serious and potentially fatal chronic diseases in their early, more treatable stages, reducing patient mortality and improving quality of life.

Learn More
The burden of chronic disease

45% of Americans suffer from at least one chronic disease.1

The biological process of a chronic disease can progress within the body for decades, but most people learn about their condition only when the symptoms escalate and become troublesome. For many of these people, years of high-cost tests and invasive methods follow, and all too often patients get an incorrect diagnosis and consequently the wrong treatment.

What if there were a test that could rapidly detect chronic disease before the condition escalates?

Through our research, we are developing a technology that detects chronic disease quickly and definitively.

1 An Empirical Study of Chronic Diseases in the United States, W Raghupathi, V Raghupathi, Int J Environ Res Public Health. 2018; 15(3): 431
Learn More
Metfora Diagnostics


The Metfora Diagnostics AI-enabled blood test is a powerful new diagnostic tool, driving a shift in healthcare to early diagnosis and intervention, improving patient care and reducing unnecessary medical costs. The test analyzes circulating metabolites to detect disease-driven metabolic changes.  Machine learning is used to extract the metabolite patterns which we term “metabolic fingerprints”.

A blood draw is performed during the annual exam or in response to symptoms

Circulating metabolites in the blood are analyzed using HPLC and mass spectrometry

“Metabolic fingerprints” are identified using algorithms developed by machine learning